Covid unmasks need for better mental health medication

As researchers continue working around the clock to put together the puzzle pieces needed for better understanding Covid-19 pathology, the disease has further exposed a serious lack of treatments for mental health conditions.

In Sweden, biotech Gabather is developing new treatments for CNS diseases, including psychiatric disorders that appear in many Covid-19 patients. BioStock got.